Literature DB >> 8521450

Linkage of silver to antibodies through 2-imino thiolane.

D K Hazra1, G T Stevenson, K S Kan.   

Abstract

Earlier studies described the linkage of silver to antibodies using SH groups generated by the reduction of the SS groups using ascorbic acid (1) analogous to the Thakur and DeFulvio technique for linking technetium to antibodies. This work describes the linkage of silver to IgG after introducing SH groups by coupling the IgG to 2-imino thiolane. The protein was dissolved in sodium acetate buffer pH 4.5 containing 1 mM EDTA by dialysis/gel chromatography in a concentration of 20 mg/mL. 2-Imino thiolane dissolved in Tris-HCl acetate buffer, pH 8.2, 0.2M was added to give a final dilution of 0.2 mM 2-imino thiolane. The excess of 2-imino thiolane was removed by dialysis or G-25 Sephadex gel chromatography and then the protein was reacted with silver nitrate 0.1 mM. The unreacted SH groups were blocked by adding iodoacetamide to a concentration of 5 mM. The nonprotein reagents again were removed by dialysis or gel chromatography. The thiol groups were titrated using 1.5 mM 2 2-Py-SS-Py prior to and after addition of silver. It was observed that depending on the concentration of silver, 50-80% of the SH groups were coupled to silver. Higher concentrations of silver led to insoluble precipitates and should be avoided.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8521450     DOI: 10.1007/BF02791579

Source DB:  PubMed          Journal:  Cell Biophys        ISSN: 0163-4992


  1 in total

1.  Linking radiosilver to monoclonal antibodies reduced by ascorbic acid. Comparison of results with stable silver using gravimetric technique and silver 110-M using radiotracer technique.

Authors:  D K Hazra; V L Lahiri; A K Gupta; N K Painuly; M Pathak; P Khanna; R K Gupta; P Khanna-Hazra; S Saran
Journal:  Cell Biophys       Date:  1994
  1 in total
  1 in total

1.  Highly Stable Silver(I) Complexes with Cyclen-Based Ligands Bearing Sulfide Arms: A Step Toward Silver-111 Labeled Radiopharmaceuticals.

Authors:  Marianna Tosato; Mattia Asti; Marco Dalla Tiezza; Laura Orian; Daniel Häussinger; Raphael Vogel; Ulli Köster; Mikael Jensen; Alberto Andrighetto; Paolo Pastore; Valerio Di Marco
Journal:  Inorg Chem       Date:  2020-07-13       Impact factor: 5.165

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.